166 studies found for:    "Poliomyelitis"
Show Display Options
Rank Status Study
21 Completed Immunogenicity and Safety of a Fractional Booster Dose of IPV Intradermally Versus Full Dose Intramuscularly
Condition: Poliomyelitis
Intervention: Biological: Inactivated types 1, 2, and 3 poliovirus, D antigens
22 Withdrawn Diarrhea and Oral Polio Vaccine Immunity
Conditions: Poliomyelitis Seroconversion;   Diarrhea
Interventions: Drug: Nitazoxanide;   Drug: Placebo
23 Completed Study of SP059 Given Subcutaneously as a Three-dose Primary and Booster Vaccination in Infants in Japan
Conditions: Poliomyelitis;   Polio
Intervention: Biological: Inactive Poliovirus Vaccine
24 Active, not recruiting Exploration of the Biologic Basis for Underperformance of Oral Polio and Rotavirus Vaccines in Bangladesh
Conditions: Rotavirus Diarrhea;   Polio Serum Neutralizing Antibody;   Polio Vaccine Virus Shedding;   Tropical Enteropathy
Interventions: Biological: IPV;   Biological: Rotarix
25 Completed Safety and Immunogenicity Study of Concomitant Versus Non Concomitant Administration of a Diphtheria, Tetanus, Pertussis and Poliomyelitis Vaccine (REPEVAX) and Influenza Vaccine (VAXIGRIP) in Subjects Aged From 60 Years Old
Conditions: Diphtheria;   Tetanus;   Pertussis;   Poliomyelitis
Interventions: Biological: Concomitant administration;   Biological: Separate administration
26 Completed Comparison of Immune Response Using 2 Vaccination Schedules Using Inactivated Polio Vaccine
Condition: Poliomyelitis
Interventions: Biological: Vaccination with inactivated polio vaccine;   Procedure: Collection of serum
27 Completed Immunogenicity and Safety of Booster Dose of BoostrixTM Polio Vaccine in Previously Boosted Adults
Conditions: Acellular Pertussis;   Poliomyelitis;   Diphtheria;   Tetanus
Intervention: Biological: BoostrixTM Polio
28 Completed Immunogenicity and Safety of GSK Biologicals' Boostrix Polio Vaccine in 3 and 4-year-old Children
Conditions: Acellular Pertussis;   Poliomyelitis;   Tetanus;   Diphtheria
Interventions: Biological: Boostrix PolioTM;   Biological: RepevaxTM;   Biological: PriorixTM
29 Completed Immunogenicity and Reactogenicity of DTPa-HBV-IPV/Hib Vaccine Followed by the Same Vaccine and Oral Polio Vaccine
Conditions: Hepatitis B;   Diphtheria;   Haemophilus Influenzae Type b (Hib);   Poliomyelitis;   Pertussis;   Tetanus
Interventions: Biological: DTPa-HBV-IPV/Hib (Infanrix hexa™);   Biological: OPV
30 Completed Immunogenicity and Safety of Fractional Doses of IPV Intradermally vs Full Doses Intramuscularly
Condition: Poliomyelitis
Intervention: Biological: Inactivated Poliomyelitis vaccine (IMOVAX)
31 Completed Immunogenicity and Safety Study of GlaxoSmithKline Biologicals' Poliorix™ Vaccine
Conditions: Poliomyelitis;   Poliomyelitis Vaccines
Interventions: Biological: Poliorix™;   Biological: Oral Poliovirus vaccine
32 Active, not recruiting Safety and Immunogenicity of 1 or 2 Doses of IPV in Latin American Infants Primed With Bivalent OPV Vaccine
Condition: Poliomyelitis
Interventions: Biological: Bivalent Oral Polio Vaccine (bOPV);   Biological: Trivalent Oral Polio Vaccine (tOPV);   Biological: Monovalent Oral Polio Vaccine Type 2 (mOPV2);   Biological: Sanofi-Pasteur IPV (Sanofi IPV);   Biological: Glaxo SmithKline IPV (GSK IPV);   Biological: Serum Institute of India IPV (SII IPV)
33 Terminated Feasibility Study of GlaxoSmithKline Biologicals' GSK2202083A Vaccine in Healthy Infants at 3, 5 and 11 Months of Age.
Conditions: Haemophilus Influenzae Type b;   Poliomyelitis;   Hepatitis B;   Serogroup C Meningococcal Diseases;   Diphtheria;   Pertussis;   Diphtheria-Tetanus-aPertussis-Hepatitis B-Poliomyelitis-Haemophilus Influenzae Type b-Neisseria Meningitidis Vaccines;   Tetanus
Interventions: Biological: GSK2202083A vaccine;   Biological: Infanrix hexa;   Biological: Menjugate
34 Active, not recruiting Exploration of the Biologic Basis for Underperformance of Oral Polio and Rotavirus Vaccines in INDIA (PROVIDE)
Conditions: Poliomyelitis;   Tropical Enteropathy
Intervention: Biological: IPV vaccination
35 Completed Antibody Persistence to REVAXIS or DT Polio and Immune Response to TETRAVAC-ACELLULAIRE
Conditions: Diphtheria;   Tetanus;   Poliomyelitis
Intervention: Biological: Diphtheria, tetanus, polio and pertussis vaccination
36 Recruiting Regulatory Post-Marketing Surveillance Study for TETRAXIM™
Conditions: Diphtheria;   Tetanus;   Pertussis;   Poliomyelitis
Intervention: Biological: TETRAXIM™: Combined adsorbed diphtheria, tetanus, acellular pertussis and enhanced inactivated polio
37 Completed
Has Results
Study to Evaluate the Safety of Co-administration of GSK Biologicals' Poliorix and Infanrix in Healthy Children in Russia
Condition: Poliomyelitis
Interventions: Biological: Poliorix TM;   Biological: Infanrix TM
38 Completed Study to Compare Pediacel® to Infanrix®-IPV+Hib When Both Are Co-Administered With Prevenar® in Infants and Toddlers
Conditions: Diphtheria;   Tetanus;   Pertussis;   Poliomyelitis;   Haemophilus Influenzae Type b
Interventions: Biological: PEDIACEL® and Prevenar®;   Biological: Infanrix®-IPV+Hib and Prevenar®
39 Completed Safety and Immunogenicity of a New Inactivated Polio Vaccine in Healthy Adults
Condition: Poliomyelitis
Interventions: Drug: IPV;   Drug: Sabin-IPV;   Drug: Adjuvanted Sabin-IPV
40 Completed Assess the Safety & Reactogenicity of DTPa-IPV/Hib Vaccine Administered at 3, 4, 5 & 18 Mths of Age, in Healthy Infants
Conditions: Diphtheria, Tetanus, Pertussis, Poliomyelitis & Haemophilus Influenzae Type b Disease;   Diphtheria-Tetanus-aPertussis-Poliomyelitis Vaccines
Intervention: Biological: GSK Biologicals' combined DTPa-IPV/Hib vaccine

Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results
Indicates status has not been verified in more than two years